Takara Bio Europe Cellartis MSC EV Wonder GMP-grade medium

Takara Bio Europe has introduced a Good Manufacturing Practice (GMP)-grade version of Cellartis MSC EV Wonder — its defined, xeno-free medium developed for the efficient and scalable production of extracellular vesicles (EVs) from human mesenchymal stem cells (MSCs).

MSC-derived EVs are gaining increasing attention as promising candidates for next-generation cell-free therapies, particularly in regenerative medicine, immunomodulation and drug delivery. However, translating EV-based approaches from laboratory research to clinical applications requires consistent production processes, reproducible product quality and suitable manufacturing materials.

Originally developed to address challenges in EV yield and reproducibility, Cellartis MSC EV Wonder has demonstrated up to a ninefold increase in EV production compared with conventional DMEM while maintaining essential EV characteristics, including canonical CD marker expression, morphology and RNA profiles. Its defined, phenol red-free formulation shares the same basal medium as the Cellartis MSC Xeno-Free Culture System, facilitating a streamlined workflow from MSC expansion to EV production.

With the introduction of the GMP-grade version, Takara Bio Europe aims to further support developers seeking to establish robust and scalable MSC-EV manufacturing workflows. The availability of the medium provides an additional option for organisations advancing EV-based applications towards clinical translation, where material quality, process consistency and manufacturing controls become increasingly important.